| Literature DB >> 26504089 |
Yongkang Zou1, Ning Gong1, Ying Cui1, Xiaojuan Wang1, Anfang Cui1, Qi Chen1, Tao Jiao1, Xueyu Dong1, Hao Yang1, Shutian Zhang2, Fude Fang1, Yongsheng Chang3.
Abstract
Dysregulation of hepatic gluconeogenesis contributes to the pathogenesis of diabetes, yet the detailed molecular mechanisms remain to be fully elucidated. Here we show that FOXP1, a transcriptional repressor, plays a key role in the regulation of systemic glucose homeostasis. Hepatic expression levels of FOXP1 are decreased in diabetic mice. Modest hepatic overexpression of FOXP1 in mice inhibited the expression of gluconeogenic genes, such as peroxisome proliferators-activated receptor γ coactivator-1α (PGC-1α), phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6-phosphatase (G6PC), leading to a decrease in hepatic glucose production and fasting blood glucose levels in normal mice and different mouse models of diabetes, including db/db diabetic and high-fat diet-induced obese mice. FOXP1 physically interacted with FOXO1 in vivo and competed with FOXO1 for binding to the insulin response element in the promoter region of gluconeogenic genes, thereby interfering expression of these genes. These results identify a previously unrecognized role for FOXP1 in the transcriptional control of hepatic glucose homeostasis.Entities:
Keywords: gluconeogenesis; glucose; hemostasis; transcription regulation; type 2 diabetes
Mesh:
Substances:
Year: 2015 PMID: 26504089 PMCID: PMC4683280 DOI: 10.1074/jbc.M115.681627
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157